Updated Jul 16, 2026
Serafin Andrew is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

According to the SEC filing with CIK 0001821460 and dated 2026-01-26, Andrew Serafin serves as Chief Strategy Officer of Harmony Biosciences Holdings, Inc. In this role, he is involved in shaping the company’s strategic direction and growth initiatives. The filing indicates no stock purchases or sales by him at that time.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-26 | HRMY | Harmony Biosciences Holdings, Inc. | F — Tax withholding / forfeiture | 1.1K | $36.82 | $41K |
| 2026-01-26 | HRMY | Harmony Biosciences Holdings, Inc. | M — Option exercise | 2.6K | $0.00 | |
| 2026-01-26 | HRMY | Harmony Biosciences Holdings, Inc. | F — Tax withholding / forfeiture | 1.1K | $36.82 | $41K |
| 2026-01-26 | HRMY | Harmony Biosciences Holdings, Inc. | M — Option exercise | 2.5K | $0.00 |
According to the SEC filing with CIK 0001821460 and dated 2026-01-26, Andrew Serafin serves as Chief Strategy Officer of Harmony Biosciences Holdings, Inc. In this role, he is involved in shaping the company’s strategic direction and growth initiatives. The filing indicates no stock purchases or sales by him at that time.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Serafin Andrew profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.